542 related articles for article (PubMed ID: 28778423)
1. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
Matusiewicz AK; Melbostad HS; Heil SH
Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.
Rey CN; Badger GJ; Melbostad HS; Wachtel D; Sigmon SC; MacAfee LK; Dougherty AK; Heil SH
Contraception; 2020 May; 101(5):333-337. PubMed ID: 32014521
[TBL] [Abstract][Full Text] [Related]
3. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
4. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
[TBL] [Abstract][Full Text] [Related]
5. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
6. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
Thompson CM; Broecker J; Dade M
J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
[TBL] [Abstract][Full Text] [Related]
7. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
[TBL] [Abstract][Full Text] [Related]
8. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder.
Smith C; Morse E; Busby S
J Perinat Neonatal Nurs; 2019; 33(2):E3-E11. PubMed ID: 31021945
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
Ihongbe TO; Masho SW
J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
[TBL] [Abstract][Full Text] [Related]
10. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
12. The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives.
Muthamia M; Owino K; Nyachae P; Kilonzo M; Kamau M; Otai J; Kabue M; Keyonzo N
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S44-59. PubMed ID: 27540124
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
14. Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance.
Burke HM; Packer CA; Spector HL; Hubacher D
Women Health; 2019 Mar; 59(3):266-280. PubMed ID: 29920171
[TBL] [Abstract][Full Text] [Related]
15. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
[TBL] [Abstract][Full Text] [Related]
18. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
19. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
20. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
Eeckhaut MCW; Rendall MS; Zvavitch P
Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]